2022 European guideline for the management of balanoposthitis

被引:18
作者
Edwards, Sarah K. [1 ]
Bunker, Christopher B. [2 ]
van der Snoek, Eric M. [3 ]
van der Meijden, Willem I. [4 ]
机构
[1] Abbey View Clin, iCasH Suffolk, 9-10 Churchyard, Bury St Edmunds IP33 1RX, England
[2] Univ Coll London Hosp, Dept Dermatol, London, England
[3] Cent Mil Hosp, Dept Dermatol, Utrecht, Netherlands
[4] Betsi Cadwaladr Univ Hlth Board BCUHB, Dept Dermatol, Bangor, Wales
关键词
CARCINOMA IN-SITU; GENITAL LICHEN-SCLEROSUS; PLASMA-CELL BALANITIS; TOPICAL CALCINEURIN INHIBITORS; ZOONS BALANITIS; ATOPIC-DERMATITIS; XEROTICA OBLITERANS; MUPIROCIN OINTMENT; CLINICAL SPECTRUM; PENILE;
D O I
10.1111/jdv.18954
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThis guideline is an update to the 2014 edition of the European guideline for the management of balanoposthitis. Balanoposthitis describes inflammation of the glans penis and prepuce and is caused by a range of disparate conditions including infection, dermatoses and premalignancy. ObjectiveThe main objectives of this guideline are to aid recognition of the symptoms and signs and complications of penile skin conditions and to offer recommendations on the diagnostic tests and treatment for a selected group of these conditions. MethodsThe previous guideline was updated following a literature review and priority was given to randomized controlled trial and systematic review evidence. ResultsThe updated guideline includes amended management for infective balanitis to provide clear guidance for Group A streptococcal infections, management of on going Lichen sclerosus (to include circumcision and supportive management to reduce the recurrence of genital herpes and warts), additional regimens for Zoonoid change, use of calcineurin inhibitors in management and risk of premalignancy and change of nomenclaturefrom Premalignant conditions to Penile Intraepithelial neoplasia (PeIN). ConclusionBalanoposthitis has a widerange of causes high quality evidence specific to the management of penile disease is not available for all the conditions described.
引用
收藏
页码:1104 / 1117
页数:14
相关论文
共 101 条
[1]   Zoon's balanitis treated with erbium:YAG laser ablation [J].
Albertini, JG ;
Holck, DEE ;
Farley, MF .
LASERS IN SURGERY AND MEDICINE, 2002, 30 (02) :123-126
[2]   Treatment of Carcinoma In Situ of the Glans Penis with Topical Chemotherapy Agents [J].
Alnajjar, Hussain M. ;
Lam, Wayne ;
Bolgeri, Marco ;
Rees, Rowland W. ;
Perry, Matthew J. A. ;
Watkin, Nicholas A. .
EUROPEAN UROLOGY, 2012, 62 (05) :923-928
[3]   Frequency of bacteria, Candida and Malassezia species in balanoposthitis [J].
Alsterholm, Mikael ;
Flytstrom, Ingela ;
Leifsdottir, Ragna ;
Faergemann, Jan ;
Bergbrant, Ing-Marie .
ACTA DERMATO-VENEREOLOGICA, 2008, 88 (04) :331-336
[4]  
[Anonymous], 2016, EAU GUIDELINES PENIL
[5]   Two cases of Zoon's balanitis treated with pimecrolimus 1% cream [J].
Bardazzi, F. ;
Antonucci, Angela ;
Savoia, F. ;
Balestri, R. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (02) :198-201
[6]   Successful Management of Zoon's Balanitis with Topical Mupirocin Ointment: A Case Report and Literature Review of Mupirocin-Responsive Balanitis Circumscripta Plasmacelluaris [J].
Bari, Omar ;
Cohen, Philip R. .
DERMATOLOGY AND THERAPY, 2017, 7 (02) :203-210
[7]   The use of topical calcineurin inhibitors in dermatology: Safety concerns - Report of the American Academy of Dermatology Association Task Force [J].
Berger, TG ;
Duvic, M ;
Van Voorhees, AS ;
Frieden, IJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) :818-823
[8]  
BIRLEY HDL, 1993, GENITOURIN MED, V69, P400
[9]   Zoon balanitis-does it exist? [J].
Bunker, C. B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (03) :E116-E117
[10]   EDF lichen sclerosus guideline [J].
Bunker, C. B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) :E97-E98